Genetic testing for inherited cardiovascular diseases: a scientific statement from the American Heart Association
…, NJ Klinedinst, AP Landstrom, VN Parikh… - Circulation: Genomic …, 2020 - Am Heart Assoc
Advances in human genetics are improving the understanding of a variety of inherited
cardiovascular diseases, including cardiomyopathies, arrhythmic disorders, vascular disorders, …
cardiovascular diseases, including cardiomyopathies, arrhythmic disorders, vascular disorders, …
[HTML][HTML] Vascular stiffness mechanoactivates YAP/TAZ-dependent glutaminolysis to drive pulmonary hypertension
…, KJ Haley, AB Waxman, VN Parikh… - The Journal of …, 2016 - Am Soc Clin Investig
Dysregulation of vascular stiffness and cellular metabolism occurs early in pulmonary
hypertension (PH). However, the mechanisms by which biophysical properties of the vascular …
hypertension (PH). However, the mechanisms by which biophysical properties of the vascular …
MicroRNA-21 integrates pathogenic signaling to control pulmonary hypertension: results of a network bioinformatics approach
VN Parikh, RC Jin, S Rabello, N Gulbahce, K White… - Circulation, 2012 - Am Heart Assoc
Background— Pulmonary hypertension (PH) is driven by diverse pathogenic etiologies. Owing
to their pleiotropic actions, microRNA molecules are potential candidates for coordinated …
to their pleiotropic actions, microRNA molecules are potential candidates for coordinated …
Phenotypic expression, natural history, and risk stratification of cardiomyopathy caused by filamin C truncating variants
…, CA James, B Murray, C Tichnell, VN Parikh… - Circulation, 2021 - Am Heart Assoc
Background: Filamin C truncating variants (FLNCtv) cause a form of arrhythmogenic
cardiomyopathy: the mode of presentation, natural history, and risk stratification of FLNCtv remain …
cardiomyopathy: the mode of presentation, natural history, and risk stratification of FLNCtv remain …
Regional Variation in RBM20 Causes a Highly Penetrant Arrhythmogenic Cardiomyopathy
VN Parikh, C Caleshu, C Reuter… - Circulation: Heart …, 2019 - Am Heart Assoc
Background Variants in the cardiomyocyte-specific RNA splicing factor RBM20 have been
linked to familial cardiomyopathy, but the causative genetic architecture and clinical …
linked to familial cardiomyopathy, but the causative genetic architecture and clinical …
Androgen level and male social status in the African cichlid, Astatotilapia burtoni
VN Parikh, TS Clement, RD Fernald - Behavioural Brain Research, 2006 - Elsevier
In vertebrates, circulating androgen levels are regulated by the hypothalamic-pituitary-gonadal
(HPG) axis through which the brain controls the gonads via the pituitary. Androgen levels …
(HPG) axis through which the brain controls the gonads via the pituitary. Androgen levels …
Worldwide differences in primary prevention implantable cardioverter defibrillator utilization and outcomes in hypertrophic cardiomyopathy
Aims Risk stratification algorithms for sudden cardiac death (SCD) in hypertrophic
cardiomyopathy (HCM) and regional differences in clinical practice have evolved over time. We …
cardiomyopathy (HCM) and regional differences in clinical practice have evolved over time. We …
Patient-specific induced pluripotent stem cells implicate intrinsic impaired contractility in hypoplastic left heart syndrome
A, Induced pluripotent stem cells (iPSCs) were derived from patients with hypoplastic left
heart syndrome (HLHS) and controls. IPSCs were differentiated into cardiomyocytes (iPSC-CMs…
heart syndrome (HLHS) and controls. IPSCs were differentiated into cardiomyocytes (iPSC-CMs…
Apelin and APJ orchestrate complex tissue-specific control of cardiomyocyte hypertrophy and contractility in the hypertrophy-heart failure transition
VN Parikh, J Liu, C Shang, C Woods… - American Journal …, 2018 - journals.physiology.org
The G protein-coupled receptor APJ is a promising therapeutic target for heart failure.
Constitutive deletion of APJ in the mouse is protective against the hypertrophy-heart failure …
Constitutive deletion of APJ in the mouse is protective against the hypertrophy-heart failure …
Emerging Genotype–Phenotype associations in dilated cardiomyopathy
…, JC Mangena, C Aribeana, VN Parikh - Current Cardiology …, 2022 - Springer
Purpose of Review The disease burden of inherited dilated cardiomyopathy (DCM) is large
and likely underestimated. This population stands to benefit immensely from therapeutic …
and likely underestimated. This population stands to benefit immensely from therapeutic …
